ibopamine has been researched along with Chronic Illness in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (45.00) | 18.7374 |
| 1990's | 7 (35.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, AF; Ganteris-Gerritsen, E; Jansen, J; Mulder, PG; Ugahary, LC; van Meurs, JC | 1 |
| Cohen, AC; Ganteris, E; Jansen, J; Mulder, PG; Ugahary, LC; van Meurs, JC; Veckeneer, M | 1 |
| Iliev, ME; Windisch, BK | 1 |
| Colí, L; Docci, D; Mosconi, G; Prandini, R; Stefoni, S; Vangelista, A | 1 |
| Andrews, R; Cowley, AJ; Evans, A; Walsh, JT | 1 |
| Anthonio, RL; Brodde, OE; de Graeff, PA; Hegeman, H; Lie, KI; Scholtens, E; Schulze, C; van Gilst, WH; van Veldhuisen, DJ; Wesseling, H | 1 |
| Buikema, H; de Graeff, PA; de Smet, BJ; Girbes, AR; Lie, KI; Scholtens, E; van Gilst, WH; van Veldhuisen, DJ; Wesseling, H | 1 |
| Girbes, AR; Kruik, J; Lie, KI; Szabó, BM; van der Burgh, PH; van Veldhuisen, DJ | 1 |
| Coats, AJ; Niebauer, J | 1 |
| Van Veldhuisen, DJ | 1 |
| Boomsma, F; Charlesworth, A; de Kam, PJ; de Zeeuw, D; Girbes, AR; Hampton, JR; Hillege, HL; van Veldhuisen, DJ | 1 |
| Itoh, H; Koike, A; Nakamura, S; Sato, Y; Taniguchi, K; Tsujibayashi, T | 1 |
| Alicandri, C; Boni, E; Fariello, R; Muiesan, G; Zaninelli, A | 1 |
| Cantoni, V; Cicchetti, V; Ghirardi, P; Marchetti, GV; Rolandi, E; Sabino, F | 1 |
| Hasenfuss, G; Just, H | 1 |
| Dei Cas, L; Manca, C; Metra, M; Nodari, S; Riva, S; Visioli, O | 1 |
| Bianco, L; Cantoni, V; Cicchetti, V; Ghirardi, P; Marchetti, GV; Sabino, F | 1 |
| Benassi, A; Mattioli, G; Modena, MG | 1 |
| Castellaccio, M; Dore, L; Ibba, GV; Sannia, L | 1 |
| Avanzini, Z; Bellogini, GC; Brusoni, B; Ciampani, N; Dei Cas, L; Gazzola, U; Maggi, GC; Mangiavacchi, M; Metra, M; Pinca, L | 1 |
1 review(s) available for ibopamine and Chronic Illness
| Article | Year |
|---|---|
Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Chronic Disease; Deoxyepinephrine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Vasodilator Agents | 1989 |
9 trial(s) available for ibopamine and Chronic Illness
| Article | Year |
|---|---|
Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma.
Topics: Administration, Topical; Adult; Aged; Chronic Disease; Cross-Over Studies; Deoxyepinephrine; Dopamine Agonists; Double-Blind Method; Eye Injuries, Penetrating; Female; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypotension; Prospective Studies; Tonometry, Ocular; Uveitis; Visual Acuity; Vitrectomy | 2006 |
Long-term treatment of chronic renal insufficiency with Ibopamine (SB 7505), a new orally active dopamine-related drug.
Topics: Administration, Oral; Adult; Aged; Chronic Disease; Clinical Trials as Topic; Creatinine; Deoxyepinephrine; Diuretics; Dopamine; Female; Glomerulonephritis; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nephritis, Interstitial; Pyelonephritis | 1982 |
Failure of "effective" treatment for heart failure to improve normal customary activity.
Topics: Activities of Daily Living; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Deoxyepinephrine; Dopamine Agonists; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Indoles; Isosorbide Dinitrate; Male; Middle Aged; Single-Blind Method; Treatment Failure; Vasodilator Agents | 1995 |
Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Autonomic Nervous System; Blood Gas Analysis; Cardiotonic Agents; Chemotherapy, Adjuvant; Chronic Disease; Deoxyepinephrine; Double-Blind Method; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Radioimmunoassay; Renin | 1996 |
Renal function, neurohormonal activation, and survival in patients with chronic heart failure.
Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Cardiac Output; Cardiotonic Agents; Catecholamines; Chronic Disease; Deoxyepinephrine; Dopamine; Epinephrine; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Male; Middle Aged; New York; Norepinephrine; Predictive Value of Tests; Prognosis; Prospective Studies; Protein Precursors; Renin; Renin-Angiotensin System; Survival Analysis; Ventricular Dysfunction, Left; Ventricular Function, Left | 2000 |
Ibopamine vs. digoxin in chronic heart failure: a double-blind, crossover study.
Topics: Adult; Aged; Cardiotonic Agents; Chronic Disease; Deoxyepinephrine; Digoxin; Dopamine; Double-Blind Method; Drug Evaluation; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Oxygen Consumption; Physical Endurance; Random Allocation; Vasodilator Agents | 1989 |
Long-term therapy of chronic congestive heart failure with ibopamine: a multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Chronic Disease; Deoxyepinephrine; Dopamine; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Italy; Male; Middle Aged; Multicenter Studies as Topic; Survival Rate; Time Factors; Vasodilator Agents | 1989 |
The efficacy of ibopamine in long-term treatment of dilated cardiomyopathy. A clinical and instrumental evaluation.
Topics: Adult; Cardiomyopathy, Dilated; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Deoxyepinephrine; Dopamine; Echocardiography; Exercise Test; Female; Humans; Male; Random Allocation | 1986 |
Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
Topics: Adult; Cardiac Output; Cardiotonic Agents; Chronic Disease; Deoxyepinephrine; Dopamine; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1986 |
10 other study(ies) available for ibopamine and Chronic Illness
| Article | Year |
|---|---|
Six months treatment with ibopamine in patients with hypotony after vitreoretinal surgery for retinal detachment, uveitis or penetrating trauma.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Deoxyepinephrine; Dopamine Agonists; Eye Injuries, Penetrating; Female; Humans; Male; Middle Aged; Mydriatics; Ocular Hypotension; Ophthalmic Solutions; Retinal Detachment; Tonometry, Ocular; Uveitis; Vitreoretinal Surgery | 2012 |
[Treatment of uveitis-associated refractory ocular hypotony with topical ibopamine].
Topics: Administration, Topical; Chronic Disease; Deoxyepinephrine; Humans; Male; Mydriatics; Ocular Hypotension; Treatment Outcome; Uveitis | 2006 |
Relation between myocardial beta-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril.
Topics: Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chronic Disease; Deoxyepinephrine; Disease Models, Animal; Dopamine Agonists; Drug Therapy, Combination; Heart Rate; Hemodynamics; Isoproterenol; Male; Myocardial Infarction; Neurotransmitter Agents; Norepinephrine; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Ventricular Pressure | 1995 |
Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Chronic Disease; Deoxyepinephrine; Disease Models, Animal; Dopamine Agonists; Hemodynamics; Male; Myocardial Infarction; Myocardium; Neurotransmitter Agents; Peptidyl-Dipeptidase A; Rats; Rats, Wistar | 1994 |
Treating chronic heart failure: time to take stock.
Topics: Chronic Disease; Deoxyepinephrine; Dopamine Agonists; Heart Failure; Humans; Randomized Controlled Trials as Topic; Receptors, Dopamine | 1997 |
Treatment of mild heart failure: the place of diuretics and ibopamine.
Topics: Chronic Disease; Deoxyepinephrine; Diuretics; Dopamine Agonists; Drug Therapy, Combination; Heart Failure; Humans; Survival Rate | 1997 |
Hemodynamic effects and pharmacokinetics of long-term therapy with ibopamine in patients with chronic heart failure.
Topics: Administration, Oral; Aged; Cardiotonic Agents; Chronic Disease; Deoxyepinephrine; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Long-Term Care; Male; Metabolic Clearance Rate; Middle Aged | 1992 |
Lack of tolerance development during chronic ibopamine administration to patients with congestive heart failure.
Topics: Adult; Aged; Chronic Disease; Deoxyepinephrine; Drug Tolerance; Heart Failure; Humans; Male; Middle Aged; Vasodilator Agents | 1988 |
Treatment of heart failure following chronic cor pulmonale with ibopamine.
Topics: Aged; Aged, 80 and over; Chronic Disease; Deoxyepinephrine; Diuretics; Dopamine; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Male; Middle Aged; Pulmonary Heart Disease | 1988 |
Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure.
Topics: Adult; Aged; Body Weight; Cardiotonic Agents; Chronic Disease; Deoxyepinephrine; Dopamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Monitoring, Physiologic; Time Factors | 1986 |